We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $7.06B
1-Year Est. Return 3.43%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$19.1B
AUM Growth
-$23.3M
Cap. Flow
-$35.7M
Cap. Flow %
-0.19%
Top 10 Hldgs %
50.97%
Holding
26
New
4
Increased
5
Reduced
16
Closed
1

Top Buys

Rank Stock Value
1
HSIC icon
Henry Schein
HSIC
+$981M
2
MDT icon
Medtronic
MDT
+$580M
3
TJX icon
TJX Companies
TJX
+$244M
4
AGN
Allergan plc
AGN
+$166M
5
IQV icon
IQVIA
IQV
+$31.9M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$378M
2
TMO icon
Thermo Fisher Scientific
TMO
+$308M
3
GWW icon
W.W. Grainger
GWW
+$280M
4
PH icon
Parker-Hannifin
PH
+$261M
5
FISV
Fiserv Inc
FISV
+$229M

Sector Composition

Rank Sector Weight
1 Healthcare 36.28%
2 Financials 23.72%
3 Industrials 17.1%
4 Technology 13.95%
5 Consumer Staples 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTV icon
26
Aptiv
APTV
$12.4B
– –
-4,457,084
Closed -$378M
1
2

Similar funds

IGAM
iA Global Asset Management Quebec, Quebec, Canada $7.06B AUM 28.93% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
RPI
Railway Pension Investments London, United Kingdom $7.03B AUM 18.92% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
CWM
Circle Wealth Management Summit, New Jersey $7.02B AUM 19.32% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $6.98B AUM
DE
Defiance ETFs New York $6.98B AUM

Longview Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Longview Partners held 26 positions worth $19.1B, down 0.12% from $19.1B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Longview Partners's Q1 2018 filing shows 4 new, 5 increased, 16 reduced and 1 closed positions. Its largest new stake was Henry Schein: 17,707,167 shares worth $933M. The largest sale was Aptiv, an estimated $378M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.

  • Longview Partners's largest Q1 2018 buy was Henry Schein: 17,707,167 shares worth $933M.
  • Longview Partners added most to IQVIA in Q1 2018, an estimated $31.9M increase.
  • Longview Partners's biggest Q1 2018 reduction was Thermo Fisher Scientific, cutting an estimated $308M.
  • Longview Partners fully exited Aptiv in Q1 2018, selling an estimated $378M.
  • Longview Partners's ten largest holdings make up 51% of its $19.1B portfolio in Q1 2018.
  • Longview Partners opened 4 new positions and closed 1 in Q1 2018.
  • Longview Partners's portfolio value fell 0.12% quarter-over-quarter to $19.1B.

Based on Longview Partners's 13F filing for Q1 2018, filed 16 Apr 2018.